Source: Oral Oncology Reports. Unidade: ICB
Subjects: PARASITOLOGIA, CARCINOMA DE CÉLULAS ESCAMOSAS, NEOPLASIAS DAS GLÂNDULAS SALIVARES, CÉLULAS CULTIVADAS DE TUMOR, NEOPLASIAS DE CABEÇA E PESCOÇO, FÁRMACOS IMUNOSSUPRESSORES, ONTOLOGIA, PROTEÍNAS SALIVARES, PROTEÔMICA, CARCINOGÊNESE BUCAL
ABNT
CHAKRABORTY, Rajdeep et al. Inhibition of anti-tumour reactivity of immune cells in the salivary gland cancer: a proteomic approach. Oral Oncology Reports, v. 9, p. 9 , 2024Tradução . . Disponível em: https://doi.org/10.1016/j.oor.2024.100160. Acesso em: 06 set. 2024.APA
Chakraborty, R., Darido, C., Tay, A. P., Zaw, T., Ranganathan, S., Liu, F., & Palmisano, G. (2024). Inhibition of anti-tumour reactivity of immune cells in the salivary gland cancer: a proteomic approach. Oral Oncology Reports, 9, 9 . doi:10.1016/j.oor.2024.100160NLM
Chakraborty R, Darido C, Tay AP, Zaw T, Ranganathan S, Liu F, Palmisano G. Inhibition of anti-tumour reactivity of immune cells in the salivary gland cancer: a proteomic approach [Internet]. Oral Oncology Reports. 2024 ; 9 9 .[citado 2024 set. 06 ] Available from: https://doi.org/10.1016/j.oor.2024.100160Vancouver
Chakraborty R, Darido C, Tay AP, Zaw T, Ranganathan S, Liu F, Palmisano G. Inhibition of anti-tumour reactivity of immune cells in the salivary gland cancer: a proteomic approach [Internet]. Oral Oncology Reports. 2024 ; 9 9 .[citado 2024 set. 06 ] Available from: https://doi.org/10.1016/j.oor.2024.100160